We are live on ! Find out more
ROIV icon

Roivant Sciences

181 hedge funds and large institutions have $5.02B invested in Roivant Sciences in 2023 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 58 increasing their positions, 46 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

483% more call options, than puts

Call options by funds: $8.47M | Put options by funds: $1.45M

152% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 23

48% more capital invested

Capital invested by funds: $3.39B → $5.02B (+$1.63B)

26% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 46

23% more funds holding

Funds holding: 147181 (+34)

4.33% more ownership

Funds ownership: 60.57%64.9% (+4.3%)

0% more funds holding in top 10

Funds holding in top 10: 1010 (0)

Holders
181
Holders Change
+34
Holders Change %
+23.13%
% of All Funds
2.84%
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.16%
New
58
Increased
58
Reduced
46
Closed
23
Calls
$8.47M
Puts
$1.45M
Net Calls
+$7.02M
Net Calls Change
+$3.44M
Name Holding Trade Value Shares
Change
Change in
Stake
TI
76
Trexquant Investment
Connecticut
$2.46M +$2.18M +244,160 New
TC
77
Tejara Capital
United Kingdom
$2.42M +$165K +18,461 +8%
Amundi
78
Amundi
France
$2.31M +$1.89M +211,391 +834%
IC
79
Ikarian Capital
Texas
$2.27M -$3.13M -350,000 -61%
Citigroup
80
Citigroup
New York
$2.26M -$3.47M -388,424 -63%
ACP
81
Acuta Capital Partners
California
$2.22M +$1.97M +220,000 New
UBS AM
82
UBS AM
Illinois
$2.21M
TLP
83
Tri Locum Partners
New York
$2.04M -$1.27M -142,124 -41%
MS
84
Maven Securities
Jersey
$2.02M -$447K -50,000 -20%
UOC
85
UBS O'Connor
Illinois
$1.92M +$254K +28,386 +18%
First Trust Advisors
86
First Trust Advisors
Illinois
$1.77M -$703K -78,581 -31%
EWM
87
Edge Wealth Management
New York
$1.77M -$827K -92,500 -35%
Wells Fargo
88
Wells Fargo
California
$1.4M +$115K +12,807 +10%
Connor, Clark & Lunn Investment Management (CC&L)
89
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.37M +$1.21M +135,622 New
Skandinaviska Enskilda Banken (SEB)
90
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.31M +$1.16M +130,207 New
PA
91
Profund Advisors
Maryland
$1.29M -$68.9K -7,703 -6%
MOACM
92
Mutual of America Capital Management
New York
$1.28M +$1.13M +126,868 New
Ensign Peak Advisors
93
Ensign Peak Advisors
Utah
$1.13M +$13K +1,450 +1%
Ohio Public Employees Retirement System (OPERS)
94
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.11M +$987K +110,390 New
AR
95
Advisory Research
Illinois
$1.1M +$975K +108,952 New
Norges Bank
96
Norges Bank
Norway
$1.1M +$974K +108,932 New
AQR Capital Management
97
AQR Capital Management
Connecticut
$1.08M +$958K +107,120 New
Treasurer of the State of North Carolina
98
Treasurer of the State of North Carolina
North Carolina
$1.07M +$954K +106,610 New
CIP
99
Chartwell Investment Partners
Pennsylvania
$1.04M +$492K +54,997 +115%
Two Sigma Advisers
100
Two Sigma Advisers
New York
$1.01M -$1.01M -112,500 -53%

ROIV Hedge Fund Activity: Q2 2023 in Review

181 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q2 2023, worth a combined $5.02B — up 48% from $3.39B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new ROIV positions and 23 closed out — a net gain of 35 holders — while 58 added to existing stakes and 46 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $87.8M. The largest seller was Viking Global Investors, cutting an estimated $116M.

  • 181 institutional investors held Roivant Sciences (ROIV) as of Q2 2023, up from 147 in Q1 2023.
  • Funds reported $5.02B of Roivant Sciences stock for Q2 2023, up 48% quarter-over-quarter.
  • 58 funds opened new Roivant Sciences positions in Q2 2023 and 23 closed out, a net change of +35 holders.
  • The largest Roivant Sciences buyer in Q2 2023 was Morgan Stanley, an estimated $87.8M added.
  • The largest Roivant Sciences seller in Q2 2023 was Viking Global Investors, an estimated $116M sold.

Based on aggregated 13F filings for Q2 2023.